Number of the records: 1
The selective P-TEFb inhibitor CAN508 targets angiogenesise
- 1.Kryštof, V., Rárová, L., Liebl, J., Zahler, S., Jorda, R., Voller, J., Cankař, P. The selective P-TEFb inhibitor CAN508 targets angiogenesise. European Journal of Medicinal Chemistry. 2011, 46(9), 4289-4294. ISSN 0223-5234. E-ISSN 1768-3254. Available: doi: 10.1016/j.ejmech.2011.06.035
Number of the records: 1